Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Thromboembolic and bleeding complications during oral anticoagulation therapy in cancer patients with atrial fibrillation: a Danish nationwide population-based cohort study.

Ording AG, Horváth-Puhó E, Adelborg K, Pedersen L, Prandoni P, Sørensen HT.

Cancer Med. 2017 Jun;6(6):1165-1172. doi: 10.1002/cam4.1054. Epub 2017 May 19.

2.

AF and Venous Thromboembolism - Pathophysiology, Risk Assessment and CHADS-VASc score.

Shariff N, Aleem A, Singh M, Z Li Y, J Smith S.

J Atr Fibrillation. 2012 Oct 6;5(3):649. doi: 10.4022/jafib.649. eCollection 2012 Oct-Nov. Review.

3.

Incidence and predictors of excessive warfarin anticoagulation in patients with atrial fibrillation-The EWA study.

Jaakkola S, Nuotio I, Kiviniemi TO, Virtanen R, Issakoff M, Airaksinen KEJ.

PLoS One. 2017 Apr 20;12(4):e0175975. doi: 10.1371/journal.pone.0175975. eCollection 2017.

4.

Technical Note: Contrast free angiography of the pulmonary vasculature in live mice using a laboratory x-ray source.

Samarage CR, Carnibella R, Preissner M, Jones HD, Pearson JT, Fouras A, Dubsky S.

Med Phys. 2016 Nov;43(11):6017.

5.
6.

Outcomes of catheter-directed treatment of lower extremity deep vein thrombosis of patients presenting to a tertiary care hospital.

Sundar G, Keshava SN, Moses V, Chiramel GK, Ahmed M, Mammen S, Aggarwal S, Stephen E.

Indian J Radiol Imaging. 2016 Jan-Mar;26(1):73-80. doi: 10.4103/0971-3026.178340.

7.

From Pulmonary Embolism to Inflammatory Bowel Disease; Give Tunnel Vision up.

Tajdini M, Hosseini SM.

Emerg (Tehran). 2016 Winter;4(1):41-4.

8.

Contrast enhanced pulmonary magnetic resonance angiography for pulmonary embolism: Building a successful program.

Nagle SK, Schiebler ML, Repplinger MD, François CJ, Vigen KK, Yarlagadda R, Grist TM, Reeder SB.

Eur J Radiol. 2016 Mar;85(3):553-63. doi: 10.1016/j.ejrad.2015.12.018. Epub 2015 Dec 29. Review.

9.

Guidance for the practical management of the heparin anticoagulants in the treatment of venous thromboembolism.

Smythe MA, Priziola J, Dobesh PP, Wirth D, Cuker A, Wittkowsky AK.

J Thromb Thrombolysis. 2016 Jan;41(1):165-86. doi: 10.1007/s11239-015-1315-2. Review.

10.

Atrial Fibrillation and Non-cardiovascular Diseases: A Systematic Review.

Ferreira C, Providência R, Ferreira MJ, Gonçalves LM.

Arq Bras Cardiol. 2015 Nov;105(5):519-26. doi: 10.5935/abc.20150142. Review. English, Portuguese.

11.

Preemptive dosage reduction of nadroparin in patients with renal failure: a retrospective case series.

Russcher M, Josephus Jitta N, Kraaijenhagen RJ, Fijnheer R, Pasker-de Jong PC, Gaillard CA.

Clin Kidney J. 2013 Oct;6(5):473-7. doi: 10.1093/ckj/sft083. Epub 2013 Sep 5.

12.

Implant surgery and oral anticoagulant therapy: case report.

Miranda M, Bollero P, D'Ovidio N, Marsango V, Barlattani A Jr.

Oral Implantol (Rome). 2014 Dec 27;7(2):51-6. eCollection 2014 Apr-Jun.

13.

Cancer-associated thrombosis: an overview.

Elyamany G, Alzahrani AM, Bukhary E.

Clin Med Insights Oncol. 2014 Dec 4;8:129-37. doi: 10.4137/CMO.S18991. eCollection 2014. Review.

14.

Effectiveness of d-dimer as a screening test for venous thromboembolism: an update.

Pulivarthi S, Gurram MK.

N Am J Med Sci. 2014 Oct;6(10):491-9. doi: 10.4103/1947-2714.143278. Review.

15.

Thrombolytic treatment (alteplase; rt-Pa) in acute massive pulmonary embolism and cardiopulmonary arrest.

Dirican A, Ozkaya S, Atas AE, Ulu EK, Kitapci I, Ece F.

Drug Des Devel Ther. 2014 Jun 12;8:759-63. doi: 10.2147/DDDT.S61679. eCollection 2014.

16.

Thrombolytic therapy complemented by ECMO: successful treatment for a case of massive pulmonary thromboembolism with hemodynamic collapse.

Chon MK, Park YH, Choi JH, Lee SH, Kim JS, Kim J, Kim JH, Chun KJ.

J Korean Med Sci. 2014 May;29(5):735-8. doi: 10.3346/jkms.2014.29.5.735. Epub 2014 Apr 25.

17.

Development and validation of a primary care-based family health history and decision support program (MeTree).

Orlando LA, Buchanan AH, Hahn SE, Christianson CA, Powell KP, Skinner CS, Chesnut B, Blach C, Due B, Ginsburg GS, Henrich VC.

N C Med J. 2013 Jul-Aug;74(4):287-96.

18.

International guidelines: Adoption or adaptation by the Saudi Heart Association?

Elbarbary M.

J Saudi Heart Assoc. 2009 Jul;21(3):181-6. doi: 10.1016/j.jsha.2009.06.004. Epub 2009 Aug 5. No abstract available.

19.

Recombinant tissue plasminogen activator for massive pulmonary thromboembolism.

Samejima K, Takai Y, Matsumura H, Seki H.

BMJ Case Rep. 2013 May 23;2013. pii: bcr2013009431. doi: 10.1136/bcr-2013-009431.

20.

Evidence for treatment of muscular vein thrombosis in orthopaedic patients.

Pengas I, Nash W, Reed N, Kumar S.

J Orthop Traumatol. 2013 Sep;14(3):159-64. doi: 10.1007/s10195-013-0241-3. Epub 2013 May 7. Review.

Supplemental Content

Support Center